Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
MilliporeSigma invests €70M to triple ADC manufacturing at US site
7 months ago
Manufacturing
PacBio bets on 'inflection point' with $500 long-read genome
7 months ago
R&D
Diagnostics
Novartis highlights overall M&A track record following MorphoSys impairment
7 months ago
Deals
Pharma
In bid to lower ARIA-E, Eli Lilly tries a different dosing regimen for its Alzheimer's drug
7 months ago
R&D
Pharma
Vera’s $300M offering; Abeona resubmits treatment for rare skin disease
7 months ago
News Briefing
Two type 1 diabetes patients are insulin-free after Eledon's immunosuppressant and an islet transplant
7 months ago
R&D
GSK buys autoimmune T cell engager for $300M upfront from Chimagen
7 months ago
Deals
Eyepoint sells $100M in shares after unveiling eye disease data for drug-device asset
7 months ago
R&D
#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference
7 months ago
Pharma
FDA+
Pathos AI nabs $62M Series C as it hunts for more Phase 1 drugs with AI
7 months ago
Financing
AI
Paragon launches another company in hot PD-1xVEGF space that goes straight to reverse merger
7 months ago
Deals
Updated: Pfizer’s Covid pill powers guidance raise, but shortfall elsewhere raises questions
7 months ago
Pharma
Corrected: Genmab lines up T cell engager pact with Revitope
7 months ago
Startups
Deals
Novartis takes $800M MorphoSys writedown mere months after closing acquisition
7 months ago
Deals
R&D
Iambic attempts to ‘break the wall’ between the lab and clinic with new AI model
7 months ago
AI
#HLTH24: How Nvidia plans to provide the building blocks of AI in health tech
7 months ago
AI
Health Tech
WuXi AppTec is still signing on new clients despite Biosecure threat
7 months ago
China
Manufacturing
Pfizer’s make-or-break quarter
7 months ago
Editor's note
Pharma
Bipartisan letter questions FDA's 'narrow' interpretation for priority review vouchers
7 months ago
Pharma
FDA+
Awaiting expanded approvals, Lilly and J&J release late-stage data for Crohn's treatments
7 months ago
R&D
Pharma
BeiGene executive reportedly under investigation in China
7 months ago
China
Pharma
Biogen's full Ph2 data for IgA nephropathy drug; Sanofi invests in obesity biotech
7 months ago
News Briefing
AbbVie makes $1.4B acquisition of Alzheimer's biotech
7 months ago
Startups
Deals
HOPO Therapeutics wins up to $226M BARDA contract for heavy metal poisoning research
7 months ago
R&D
First page
Previous page
84
85
86
87
88
89
90
Next page
Last page